Cite
1224P Detection of circulating tumor DNA (ctDNA) in untreated patients (pts) with cancer: Implications for early cancer detection (ECD).
MLA
Nakamura, Y., et al. “1224P Detection of Circulating Tumor DNA (CtDNA) in Untreated Patients (Pts) with Cancer: Implications for Early Cancer Detection (ECD).” Annals of Oncology, vol. 34, Oct. 2023, p. S717. EBSCOhost, https://doi.org/10.1016/j.annonc.2023.09.2313.
APA
Nakamura, Y., Tin, T., Krinshpun, S., Mitchell, B., Bristow, S. L., Aleshin, A., Magbanua, M. J. M., Van’t Veer, L. J., Chapman, J., Lindbjerg Andersen, C., Tan, D. S. W., & Yoshino, T. (2023). 1224P Detection of circulating tumor DNA (ctDNA) in untreated patients (pts) with cancer: Implications for early cancer detection (ECD). Annals of Oncology, 34, S717. https://doi.org/10.1016/j.annonc.2023.09.2313
Chicago
Nakamura, Y., T. Tin, S. Krinshpun, B. Mitchell, S.L. Bristow, A. Aleshin, M.J.M. Magbanua, et al. 2023. “1224P Detection of Circulating Tumor DNA (CtDNA) in Untreated Patients (Pts) with Cancer: Implications for Early Cancer Detection (ECD).” Annals of Oncology 34 (October): S717. doi:10.1016/j.annonc.2023.09.2313.